Roos Nuboer

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

Pamela Bowman, Åsta Sulen, Fabrizio Barbetti et al. · The Lancet Diabetes & Endocrinology · 2018 · 175 citations · Full text

Medicine, Pediatrics, Pharmacology +15

Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene

A. S. Slingerland, Roos Nuboer, Mijna Hadders‐Algra et al. · Diabetologia · 2006 · 132 citations · Full text

Medicine, Genetics, Pediatrics +16

Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes

Henk S. Schipper, Roos Nuboer, Serge Prop et al. · Diabetologia · 2012 · 120 citations · Full text

Veterinary Medicine, Immunology, Pediatrics +14

Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison

Roos Nuboer, Gerard JJM Borsboom, Jan Age Zoethout et al. · Pediatric Diabetes · 2008 · 79 citations · Full text

Medicine, Child Health, Pediatrics +13

Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity

Marta Reyman, A. A. Verrijn Stuart, M. van Summeren et al. · International Journal of Obesity · 2013 · 71 citations · Full text

Medicine, Endocrinology, Pediatrics +17